Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs

Status:
Terminated

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

This will be a multi-center, randomized, blinded, comparative, placebo-controlled, 4 arm crossover study in patients with primary insomnia.

Phase 2

Neurogen Corporation

Adipiplon
Zolpidem